Philips launches VeriSight Pro 3D intracardiac echocardiography catheter in Europe for heart procedures

From Yahoo Finance: 2025-05-20 07:14:00

Philips has launched the VeriSight Pro 3D intracardiac echocardiography catheter in Europe, which integrates with EPIQ ultrasound systems and Azurion image-guided therapy platform for heart procedures like valve repair and closure. The catheter provides real-time 3D and 2D imaging inside the heart, improving precision with xPlane and iRotate technologies. It reduces the need for general anaesthesia, shortening hospital stays and costs. The European Commission projects structural heart disease cases in Europe to exceed 20 million by 2040, with a rise in transcatheter aortic valve replacement procedures. The global TAVR market is forecast to reach $13.7bn by 2033, with Edwards Lifesciences holding over 60% of the US market share. Medtronic’s Evolut TAVR system could disrupt the market with superior data.



Read more at Yahoo Finance: Philips launches 3D imaging catheter in Europe